1-20 of 28
Authors: E.L. Simpson
Sort by
Journal Article
Conjunctivitis in adult patients with moderate‐to‐severe atopic dermatitis: results from five tralokinumab clinical trials Open Access
A. Wollenberg and others
British Journal of Dermatology, Volume 186, Issue 3, 1 March 2022, Pages 453–465, https://doi.org/10.1111/bjd.20810
Published: 01 March 2022
Journal Article
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2) Open Access
A. Wollenberg and others
British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Pages 437–449, https://doi.org/10.1111/bjd.19574
Published: 01 March 2021
Journal Article
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials
Get access
E.L. Simpson and others
British Journal of Dermatology, Volume 183, Issue 2, 1 August 2020, Pages 242–255, https://doi.org/10.1111/bjd.18898
Published: 01 August 2020
Journal Article
评估接受 Dupilumab 治疗的中度至重度特应性皮炎患者进行常规安全性检测的必要性
Get access
A. Wollenberg and others
British Journal of Dermatology, Volume 182, Issue 6, 1 June 2020, Page e198, https://doi.org/10.1111/bjd.19077
Published: 01 June 2020
Journal Article
Assessing the need for routine safety testing for patients being treated with dupilumab for moderate‐to‐severe atopic dermatitis
Get access
A Wollenberg and others
British Journal of Dermatology, Volume 182, Issue 6, 1 June 2020, Page e186, https://doi.org/10.1111/bjd.19065
Published: 01 June 2020
Journal Article
Laboratory safety of dupilumab in moderate‐to‐severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS) Open Access
A. Wollenberg and others
British Journal of Dermatology, Volume 182, Issue 5, 1 May 2020, Pages 1120–1135, https://doi.org/10.1111/bjd.18434
Published: 01 May 2020
Includes: Multimedia
Journal Article
A comparison of five ways to measure atopic dermatitis severity in adults
Get access
J.I. Silverberg and others
British Journal of Dermatology, Volume 182, Issue 1, 1 January 2020, Page e26, https://doi.org/10.1111/bjd.18657
Published: 01 January 2020
Journal Article
Validation of five patient‐reported outcomes for atopic dermatitis severity in adults
Get access
J.I. Silverberg and others
British Journal of Dermatology, Volume 182, Issue 1, 1 January 2020, Pages 104–111, https://doi.org/10.1111/bjd.18002
Published: 01 January 2020
Journal Article
五种测量成人特应性皮炎严重程度的方法的比较
Get access
J.I. Silverberg and others
British Journal of Dermatology, Volume 182, Issue 1, 1 January 2020, Page e43, https://doi.org/10.1111/bjd.18674
Published: 01 January 2020
Journal Article
Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults Open Access
J.I. Silverberg and others
British Journal of Dermatology, Volume 181, Issue 3, 1 September 2019, Pages 554–565, https://doi.org/10.1111/bjd.17683
Published: 01 September 2019
Journal Article
成人 AD 中的心理健康
Get access
J.I. Silverberg and others
British Journal of Dermatology, Volume 181, Issue 3, 1 September 2019, Page e83, https://doi.org/10.1111/bjd.18290
Published: 01 September 2019
Journal Article
Dupilumab 临床试验中的结膜炎
Get access
B. Akinlade and others
British Journal of Dermatology, Volume 181, Issue 3, 1 September 2019, Page e81, https://doi.org/10.1111/bjd.18288
Published: 01 September 2019
Journal Article
Conjunctivitis in dupilumab clinical trials Open Access
B. Akinlade and others
British Journal of Dermatology, Volume 181, Issue 3, 1 September 2019, Pages 459–473, https://doi.org/10.1111/bjd.17869
Published: 01 September 2019
Includes: Multimedia
Journal Article
Conjunctivitis in dupilumab clinical trials
Get access
B. Akinlade and others
British Journal of Dermatology, Volume 181, Issue 3, 1 September 2019, Page e69, https://doi.org/10.1111/bjd.18276
Published: 01 September 2019
Journal Article
Mental health in adult AD
Get access
J.I. Silverberg and others
British Journal of Dermatology, Volume 181, Issue 3, 1 September 2019, Page e71, https://doi.org/10.1111/bjd.18278
Published: 01 September 2019
Journal Article
Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials Open Access
J.I. Silverberg and others
British Journal of Dermatology, Volume 181, Issue 1, 1 July 2019, Pages 80–87, https://doi.org/10.1111/bjd.17791
Published: 01 July 2019
Includes: Multimedia
Journal Article
Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials Open Access
A. Blauvelt and others
British Journal of Dermatology, Volume 181, Issue 1, 1 July 2019, Pages 196–197, https://doi.org/10.1111/bjd.17703
Published: 01 July 2019
Journal Article
Standardized reporting of the Eczema Area and Severity Index (EASI) and the Patient‐Oriented Eczema Measure (POEM): a recommendation by the Harmonising Outcome Measures for Eczema (HOME) Initiative
Get access
E.E. Grinich and others
British Journal of Dermatology, Volume 179, Issue 2, 1 August 2018, Pages 540–541, https://doi.org/10.1111/bjd.16732
Published: 01 August 2018
Journal Article
Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality‐of‐life measure for adult atopic dermatitis
Get access
A.R. Wang and others
British Journal of Dermatology, Volume 178, Issue 5, 1 May 2018, Pages 1211–1212, https://doi.org/10.1111/bjd.16398
Published: 01 May 2018
Journal Article
成年异位性皮炎患者中的五种患者报告结果的严重性等级
Get access
P.P. Vakharia and others
British Journal of Dermatology, Volume 178, Issue 4, 1 April 2018, Page e318, https://doi.org/10.1111/bjd.16581
Published: 01 April 2018
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals